Publication Information

{'id': 'https://openalex.org/W4393088548', 'doi': 'https://doi.org/10.1158/1538-7445.am2024-183', 'title': 'Abstract 183: A novel bispecific antibody macrophage engager (BiME) designed for the treatment of solid tumors', 'display_name': 'Abstract 183: A novel bispecific antibody macrophage engager (BiME) designed for the treatment of solid tumors', 'publication_year': 2024, 'publication_date': '2024-03-22', 'ids': {'openalex': 'https://openalex.org/W4393088548', 'doi': 'https://doi.org/10.1158/1538-7445.am2024-183'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2024-183', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5012040998', 'display_name': 'Dawei Sun', 'orcid': 'https://orcid.org/0000-0003-1551-4349'}, 'institutions': [{'id': 'https://openalex.org/I4210109974', 'display_name': 'Jiangsu T-mab BioPharma (China)', 'ror': 'https://ror.org/017dx9162', 'country_code': 'CN', 'type': 'company', 'lineage': ['https://openalex.org/I4210109974']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Dawei Sun', 'raw_affiliation_strings': ['1Elpiscience Biopharma, Shanghai, China.'], 'affiliations': [{'raw_affiliation_string': '1Elpiscience Biopharma, Shanghai, China.', 'institution_ids': ['https://openalex.org/I4210109974']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033825668', 'display_name': 'Haixia Jiang', 'orcid': 'https://orcid.org/0000-0001-5625-6521'}, 'institutions': [{'id': 'https://openalex.org/I4210109974', 'display_name': 'Jiangsu T-mab BioPharma (China)', 'ror': 'https://ror.org/017dx9162', 'country_code': 'CN', 'type': 'company', 'lineage': ['https://openalex.org/I4210109974']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Haixia Jiang', 'raw_affiliation_strings': ['1Elpiscience Biopharma, Shanghai, China.'], 'affiliations': [{'raw_affiliation_string': '1Elpiscience Biopharma, Shanghai, China.', 'institution_ids': ['https://openalex.org/I4210109974']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5064038033', 'display_name': 'Yanan Geng', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210109974', 'display_name': 'Jiangsu T-mab BioPharma (China)', 'ror': 'https://ror.org/017dx9162', 'country_code': 'CN', 'type': 'company', 'lineage': ['https://openalex.org/I4210109974']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Yanan Geng', 'raw_affiliation_strings': ['1Elpiscience Biopharma, Shanghai, China.'], 'affiliations': [{'raw_affiliation_string': '1Elpiscience Biopharma, Shanghai, China.', 'institution_ids': ['https://openalex.org/I4210109974']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101080489', 'display_name': 'Yue Wu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210109974', 'display_name': 'Jiangsu T-mab BioPharma (China)', 'ror': 'https://ror.org/017dx9162', 'country_code': 'CN', 'type': 'company', 'lineage': ['https://openalex.org/I4210109974']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Yue Wu', 'raw_affiliation_strings': ['1Elpiscience Biopharma, Shanghai, China.'], 'affiliations': [{'raw_affiliation_string': '1Elpiscience Biopharma, Shanghai, China.', 'institution_ids': ['https://openalex.org/I4210109974']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5087911033', 'display_name': 'Rui Gao', 'orcid': 'https://orcid.org/0000-0002-4704-206X'}, 'institutions': [{'id': 'https://openalex.org/I4210109974', 'display_name': 'Jiangsu T-mab BioPharma (China)', 'ror': 'https://ror.org/017dx9162', 'country_code': 'CN', 'type': 'company', 'lineage': ['https://openalex.org/I4210109974']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Rui Gao', 'raw_affiliation_strings': ['1Elpiscience Biopharma, Shanghai, China.'], 'affiliations': [{'raw_affiliation_string': '1Elpiscience Biopharma, Shanghai, China.', 'institution_ids': ['https://openalex.org/I4210109974']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109469348', 'display_name': 'Yefeng Lu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210109974', 'display_name': 'Jiangsu T-mab BioPharma (China)', 'ror': 'https://ror.org/017dx9162', 'country_code': 'CN', 'type': 'company', 'lineage': ['https://openalex.org/I4210109974']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Yefeng Lu', 'raw_affiliation_strings': ['1Elpiscience Biopharma, Shanghai, China.'], 'affiliations': [{'raw_affiliation_string': '1Elpiscience Biopharma, Shanghai, China.', 'institution_ids': ['https://openalex.org/I4210109974']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101542801', 'display_name': 'Quan Qiu', 'orcid': 'https://orcid.org/0000-0001-9183-7399'}, 'institutions': [{'id': 'https://openalex.org/I4210109974', 'display_name': 'Jiangsu T-mab BioPharma (China)', 'ror': 'https://ror.org/017dx9162', 'country_code': 'CN', 'type': 'company', 'lineage': ['https://openalex.org/I4210109974']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Quan Qiu', 'raw_affiliation_strings': ['1Elpiscience Biopharma, Shanghai, China.'], 'affiliations': [{'raw_affiliation_string': '1Elpiscience Biopharma, Shanghai, China.', 'institution_ids': ['https://openalex.org/I4210109974']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043615516', 'display_name': 'Yanfen Hu', 'orcid': 'https://orcid.org/0000-0001-9595-1631'}, 'institutions': [{'id': 'https://openalex.org/I4210109974', 'display_name': 'Jiangsu T-mab BioPharma (China)', 'ror': 'https://ror.org/017dx9162', 'country_code': 'CN', 'type': 'company', 'lineage': ['https://openalex.org/I4210109974']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Yanfen Hu', 'raw_affiliation_strings': ['1Elpiscience Biopharma, Shanghai, China.'], 'affiliations': [{'raw_affiliation_string': '1Elpiscience Biopharma, Shanghai, China.', 'institution_ids': ['https://openalex.org/I4210109974']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053146492', 'display_name': 'Yingchao Liu', 'orcid': 'https://orcid.org/0000-0002-6656-2511'}, 'institutions': [{'id': 'https://openalex.org/I4210109974', 'display_name': 'Jiangsu T-mab BioPharma (China)', 'ror': 'https://ror.org/017dx9162', 'country_code': 'CN', 'type': 'company', 'lineage': ['https://openalex.org/I4210109974']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Yingchao Liu', 'raw_affiliation_strings': ['1Elpiscience Biopharma, Shanghai, China.'], 'affiliations': [{'raw_affiliation_string': '1Elpiscience Biopharma, Shanghai, China.', 'institution_ids': ['https://openalex.org/I4210109974']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101507342', 'display_name': 'Xiaoli Guo', 'orcid': 'https://orcid.org/0000-0003-4569-8708'}, 'institutions': [{'id': 'https://openalex.org/I4210109974', 'display_name': 'Jiangsu T-mab BioPharma (China)', 'ror': 'https://ror.org/017dx9162', 'country_code': 'CN', 'type': 'company', 'lineage': ['https://openalex.org/I4210109974']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Xiaoli Guo', 'raw_affiliation_strings': ['1Elpiscience Biopharma, Shanghai, China.'], 'affiliations': [{'raw_affiliation_string': '1Elpiscience Biopharma, Shanghai, China.', 'institution_ids': ['https://openalex.org/I4210109974']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078871565', 'display_name': 'Xiaofeng Niu', 'orcid': 'https://orcid.org/0000-0002-8349-7010'}, 'institutions': [{'id': 'https://openalex.org/I4210109974', 'display_name': 'Jiangsu T-mab BioPharma (China)', 'ror': 'https://ror.org/017dx9162', 'country_code': 'CN', 'type': 'company', 'lineage': ['https://openalex.org/I4210109974']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Xiaofeng Niu', 'raw_affiliation_strings': ['1Elpiscience Biopharma, Shanghai, China.'], 'affiliations': [{'raw_affiliation_string': '1Elpiscience Biopharma, Shanghai, China.', 'institution_ids': ['https://openalex.org/I4210109974']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5043776328', 'display_name': 'Hongtao Lu', 'orcid': 'https://orcid.org/0000-0002-0414-5798'}, 'institutions': [{'id': 'https://openalex.org/I4210109974', 'display_name': 'Jiangsu T-mab BioPharma (China)', 'ror': 'https://ror.org/017dx9162', 'country_code': 'CN', 'type': 'company', 'lineage': ['https://openalex.org/I4210109974']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Hongtao Lu', 'raw_affiliation_strings': ['1Elpiscience Biopharma, Shanghai, China.'], 'affiliations': [{'raw_affiliation_string': '1Elpiscience Biopharma, Shanghai, China.', 'institution_ids': ['https://openalex.org/I4210109974']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 2.687, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.999952, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 84, 'max': 93}, 'biblio': {'volume': '84', 'issue': '6_Supplement', 'first_page': '183', 'last_page': '183'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10063', 'display_name': 'Nanoparticle-Based Drug Delivery', 'score': 0.9963, 'subfield': {'id': 'https://openalex.org/subfields/2502', 'display_name': 'Biomaterials'}, 'field': {'id': 'https://openalex.org/fields/25', 'display_name': 'Materials Science'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T12867', 'display_name': 'Advanced Biosensing Techniques and Applications', 'score': 0.979, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/solid-tumor', 'display_name': 'Solid tumor', 'score': 0.44819015}, {'id': 'https://openalex.org/keywords/bispecific-antibody', 'display_name': 'Bispecific antibody', 'score': 0.4344681}], 'concepts': [{'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5070181}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.45953372}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.4582514}, {'id': 'https://openalex.org/C2993640289', 'wikidata': 'https://www.wikidata.org/wiki/Q1216998', 'display_name': 'Solid tumor', 'level': 3, 'score': 0.44819015}, {'id': 'https://openalex.org/C3020495827', 'wikidata': 'https://www.wikidata.org/wiki/Q426141', 'display_name': 'Bispecific antibody', 'level': 4, 'score': 0.4344681}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.3543231}, {'id': 'https://openalex.org/C542903549', 'wikidata': 'https://www.wikidata.org/wiki/Q422248', 'display_name': 'Monoclonal antibody', 'level': 3, 'score': 0.26531312}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.221367}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.21810159}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2024-183', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.79, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4387968375', 'https://openalex.org/W4387004141', 'https://openalex.org/W4253795133', 'https://openalex.org/W2999997703', 'https://openalex.org/W2808163747', 'https://openalex.org/W2102163098', 'https://openalex.org/W2093286338', 'https://openalex.org/W2028965232', 'https://openalex.org/W2020173467', 'https://openalex.org/W2006264959'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'Anti-CD3-based': [2], 'bispecific': [3, 169, 218, 296, 334, 338, 382, 435], 'T': [4, 24, 323, 374], 'cell': [5], 'engagers': [6, 384], '(BiTE)': [7], 'showed': [8], 'limited': [9], 'clinical': [10, 396], 'efficacy': [11, 158, 256, 312], 'in': [12, 62, 100, 259, 276, 313, 343, 394], 'solid': [13, 84, 399, 445], 'tumors': [14, 85, 141, 446], 'and': [15, 76, 142, 157, 198, 208, 214, 225, 231, 247, 271, 304, 322, 327, 347, 373, 386, 390], 'caused': [16], 'significant': [17], 'cytokine': [18, 74, 353], 'storm.': [19], 'Similar': [20], 'to': [21, 49, 73, 113, 146, 329, 404], 'BiTE': [22, 405], 'where': [23, 40], 'cells': [25, 99, 324, 375], 'are': [26, 94], 'activated': [27, 43, 326], 'by': [28, 44, 229, 239, 380], 'CD3': [29], 'antibody,': [30], 'we': [31, 161, 289], 'constructed': [32, 201], 'a': [33, 50, 126, 153, 166, 174, 184, 260, 292], 'novel': [34, 367, 434], 'bi-specific': [35, 177], 'macrophage': [36, 41, 170, 246, 383, 437], 'engager': [37, 171, 438], '(BiME)': [38, 172, 439], 'platform': [39], 'is': [42, 47, 77, 125, 349], 'anti-SIRPa': [45], 'that': [46, 105, 130], 'directed': [48], 'particular': [51], 'tumor': [52, 66, 102, 262, 317, 400], 'via': [53], 'the': [54, 57, 65, 81, 101, 114, 163, 336, 381, 388, 442, 451], 'targeting': [55, 149, 195], 'of': [56, 64, 83, 90, 97, 109, 116, 135, 165, 186, 211, 294, 332, 360, 392, 444, 450], 'tumor-associated': [58], 'antigen': [59], '(TAA),': [60], 'resulting': [61], 'phagocytosis': [63, 132, 240], 'cells.': [67], 'This': [68], 'BiME': [69, 202, 287, 307, 333, 337, 361, 393], 'does': [70], 'not': [71], 'lead': [72], 'storm': [75], 'particularly': [78], 'applicable': [79], 'for': [80, 222, 398, 441, 454], 'treatment': [82, 308, 359, 401, 443], 'whose': [86], 'microenvironment': [87], 'contains': [88], 'plenty': [89], 'macrophages.': [91], 'Tumor-associated': [92], 'macrophages': [93], 'major': [95], 'component': [96], 'immune': [98, 118], 'micro-environment': [103], '(TME)': [104], 'express': [106], 'an': [107], 'array': [108], 'effector': [110], 'molecules': [111], 'leading': [112], 'inhibition': [115], 'anti-tumor': [117, 255, 311], 'responses.': [119], 'Signal': [120], 'regulatory': [121], 'protein': [122], 'α': [123], '(SIRPα)': [124], 'myeloid-lineage': [127], 'inhibitory': [128], 'receptor': [129], 'restricts': [131], 'through': [133], 'engagement': [134], 'its': [136], 'ligand': [137], 'CD47': [138], 'expressed': [139], 'on': [140], 'normal': [143], 'tissues.': [144], 'Compared': [145], 'anti-CD47': [147], 'therapeutics,': [148], 'myeloid-restricted': [150], 'SIRPα': [151, 167], 'provides': [152], 'differential': [154], 'pharmacokinetic,': [155], 'safety,': [156], 'profile.': [159], 'Here,': [160], 'report': [162], 'construction': [164], 'antagonist-based': [168], 'platform,': [173, 288], 'potent': [175], 'tumor-killing': [176], 'antibody': [178, 189, 436], 'platform.': [179], 'Methods:': [180], 'We': [181, 200], 'have': [182, 290], 'generated': [183, 291], 'panel': [185, 293], 'single': [187], 'domain': [188], '(sdAb),': [190], 'scFv': [191], 'or': [192, 280, 352], 'Fab': [193], 'antibodies': [194, 203, 219, 297, 339], 'different': [196, 205], 'TAAs': [197], 'SIRPa.': [199], 'using': [204, 242], 'orientations,': [206], 'ratios,': [207], 'IgG': [209], 'isotypes': [210], 'anti-TAA': [212], 'arm': [213], 'anti-SIRPα': [215], 'arm.': [216], 'These': [217, 364], 'were': [220, 274, 325, 340], 'evaluated': [221], 'homologue': [223], 'binding,': [224], 'CD47-SIRPα': [226], 'blocking': [227], 'properties': [228], 'ELISA': [230], 'FACS.': [232], 'In': [233, 253], 'vitro': [234], 'function': [235], 'activity': [236, 331], 'was': [237, 257], 'determined': [238], 'assay': [241], 'human': [243], 'monocyte': [244], 'derived': [245, 251], 'mouse': [248, 315], 'bone': [249], 'marrow': [250], 'macrophage.': [252], 'vivo': [254], 'tested': [258], 'syngeneic': [261, 316], 'model': [263], 'with': [264, 298], 'hSIRPα': [265, 277], 'knock-in': [266, 278], 'mice.': [267], 'The': [268, 306], 'pharmacokinetic': [269], '(PK)': [270], 'safety': [272], 'profile': [273], 'assessed': [275], 'mice': [279], 'cynomolgus': [281], 'monkeys.': [282], 'Results:': [283], 'Through': [284], 'Elpiscience': [285], 'proprietary': [286], 'TAA/SIRPα': [295], 'TAA': [299], 'being': [300], 'Claudin18.2,': [301], 'EGFR,': [302], 'PDL1': [303], 'DLL-3.': [305], 'demonstrated': [309], 'strong': [310], 'multiple': [314], 'models.': [318], 'Mechanistically,': [319], 'both': [320], 'myeloid': [321, 372], 'contributed': [328], 'antitumor': [330], 'antibody.': [335], 'well': [341], 'tolerated': [342], 'non-human': [344], 'primates': [345], '(NHPs)': [346], 'there': [348], 'no': [350], 'hematotoxicity': [351], 'release': [354], 'syndrome': [355], '(CRS)': [356], 'observed': [357], 'after': [358], 'antibodies.': [362], 'Conclusions:': [363], 'findings': [365], 'provide': [366], 'mechanistic': [368], 'insights': [369], 'into': [370], 'how': [371], 'can': [376], 'be': [377], 'uniquely': [378], 'modulated': [379], '(BiMEs)': [385], 'demonstrate': [387], 'potential': [389], 'advantage': [391], 'future': [395], 'development': [397], 'as': [402], 'compared': [403], 'approach.': [406], 'Citation': [407], 'Format:': [408], 'Dawei': [409], 'Sun,': [410], 'Haixia': [411], 'Jiang,': [412], 'Yanan': [413], 'Geng,': [414], 'Yue': [415], 'Wu,': [416], 'Rui': [417], 'Gao,': [418], 'Yefeng': [419], 'Lu,': [420], 'Quan': [421], 'Qiu,': [422], 'Yanfen': [423], 'Hu,': [424], 'Yingchao': [425], 'Liu,': [426], 'Xiaoli': [427], 'Guo,': [428], 'Xiaofeng': [429], 'Niu,': [430], 'Hongtao': [431], 'Lu.': [432], 'A': [433], 'designed': [440], '[abstract].': [447], 'In:': [448], 'Proceedings': [449], 'American': [452], 'Association': [453], 'Cancer': [455, 473], 'Research': [456], 'Annual': [457], 'Meeting': [458], '2024;': [459], 'Part': [460], '1': [461], '(Regular': [462], 'Abstracts);': [463], '2024': [464], 'Apr': [465], '5-10;': [466], 'San': [467], 'Diego,': [468], 'CA.': [469], 'Philadelphia': [470], '(PA):': [471], 'AACR;': [472], 'Res': [474], '2024;84(6_Suppl):Abstract': [475], 'nr': [476], '183.': [477]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4393088548', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}], 'updated_date': '2024-12-15T13:37:22.649686', 'created_date': '2024-03-23'}